1. Home
  2. HCWB vs HUSA Comparison

HCWB vs HUSA Comparison

Compare HCWB & HUSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCWB
  • HUSA
  • Stock Information
  • Founded
  • HCWB 2018
  • HUSA N/A
  • Country
  • HCWB United States
  • HUSA United States
  • Employees
  • HCWB N/A
  • HUSA N/A
  • Industry
  • HCWB Biotechnology: Pharmaceutical Preparations
  • HUSA Oil & Gas Production
  • Sector
  • HCWB Health Care
  • HUSA Energy
  • Exchange
  • HCWB Nasdaq
  • HUSA Nasdaq
  • Market Cap
  • HCWB 17.2M
  • HUSA 16.9M
  • IPO Year
  • HCWB 2021
  • HUSA N/A
  • Fundamental
  • Price
  • HCWB $0.39
  • HUSA $1.31
  • Analyst Decision
  • HCWB
  • HUSA
  • Analyst Count
  • HCWB 0
  • HUSA 0
  • Target Price
  • HCWB N/A
  • HUSA N/A
  • AVG Volume (30 Days)
  • HCWB 18.3M
  • HUSA 667.1K
  • Earning Date
  • HCWB 03-31-2025
  • HUSA 04-01-2025
  • Dividend Yield
  • HCWB N/A
  • HUSA N/A
  • EPS Growth
  • HCWB N/A
  • HUSA N/A
  • EPS
  • HCWB N/A
  • HUSA N/A
  • Revenue
  • HCWB $3,495,990.00
  • HUSA $640,348.00
  • Revenue This Year
  • HCWB $229.19
  • HUSA N/A
  • Revenue Next Year
  • HCWB N/A
  • HUSA N/A
  • P/E Ratio
  • HCWB N/A
  • HUSA N/A
  • Revenue Growth
  • HCWB 22.27
  • HUSA N/A
  • 52 Week Low
  • HCWB $0.21
  • HUSA $0.96
  • 52 Week High
  • HCWB $2.52
  • HUSA $3.20
  • Technical
  • Relative Strength Index (RSI)
  • HCWB 48.72
  • HUSA 41.89
  • Support Level
  • HCWB $0.38
  • HUSA $1.33
  • Resistance Level
  • HCWB $0.42
  • HUSA $1.49
  • Average True Range (ATR)
  • HCWB 0.09
  • HUSA 0.10
  • MACD
  • HCWB -0.00
  • HUSA -0.01
  • Stochastic Oscillator
  • HCWB 4.48
  • HUSA 2.22

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

About HUSA Houston American Energy Corporation

Houston American Energy Corp is an independent oil and gas company focused on the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties. Its properties, and operations, are in the U.S. Permian Basin, the U.S. Gulf Coast region, particularly Texas and Louisiana, and the South American country of Colombia. The company's exploration and development projects are focused on existing property interests, and future acquisition of additional property interests, in the Texas Permian Basin, the onshore Texas and Louisiana Gulf Coast region, and the South American country of Colombia. The Company majorly has operations in two geographical areas, the United States and Colombia.

Share on Social Networks: